This is wrong @SecKennedy. You are putting children and adults at risk by denying years of research and accumulated evidence disproving links between vaccination and autism. This is not the MAHA you promised. #misinformation https://t.co/wEicoqRaZ6 via @NYTimes

Just learned about limbic-predominant age-related TDP-43 encephalopathy (LATE) that can be confused for Alzheimer. LATE affects primarily the hippocampus and manifests as memory loss. Alone is less severe than AD but together makes AD worse. #Alzheimer

In this @EricTopol podcast, @DrJenGunter argues that the @US_FDA's new HRT guidelines for postmenopausal use are more of a PR move than evidence-based and warns that this administration might use it to promote other false narratives in women's health #WomensHealth #MRT

Not a good thing when one reads about Dr. Ralph Abraham becoming the No. 2 at the CDC, despite a track record of downplaying vaccines and delaying outbreak alerts. Hard not to worry about what this means for public health decisions ahead. #CDC #PublicHealth

Concerning off label increased use of GLP-1 semaglutide during postpartum according to this JAMA study w/o knowing the effects on lactation and metabolic changes during this period #GLP1 #postpartum https://t.co/7PTGkW5dhi

If you’re on GLP-1’s and experiencing chronic cough, there might a link between the 2, according to this recent JAMA study #GLP1 #cough Glucagon-Like Peptide-1 Receptor Agonists and Chronic Cough

This is a setback for the idea that GLP-1s could be useful for Alzheimer’s patients. Let’s hope other ongoing trials using different GLP-1s show better results. #Alzheimer #NovoNordisk

Reading the latest flu outlook and it doesn’t look great. A faster-spreading variant is picking up, and cases are surging. The vaccine won’t block all infections, but it still cuts severe disease. Did you already get your shot? #FluSeason https://t.co/kdkkwrHLLe via @NYTimes

Just listened to a piece on personalized cancer vaccines built from mRNA. The science is incredible, targeting each patient’s unique tumor mutations. But misinformation, funding and public trust are shaky, and that could slow real progress. #CancerResearch

More evidence of the importance of physical activity as we age to prevent mental deterioration.

New data show that many cancers don’t just spread, they invade major blood vessels and release surges of tumor cell clusters right before death. These vascular failures may be key drivers of lethality and targets for new therapies #CancerResearch #Oncology

New research shows brain tumors contain bacterial fragments, not live bacteria.These fragments activate the body’s defense system inside the tumor and often match bacteria from a patient’s mouth.This may change how we to treat brain tumors. #BrainTumor

For a person like me on statins for atherosclerosis, it is great to learn that there are ways to stratify cardiovascular event risk by studying plaque composition and inflammation, and a better arsenal of drugs to decrease cardiovascular morbidity. https://t.co/rbWnc0dEnZ

Just read a deep dive on why so many people are turning to A.I. for medical advice. Contrasting to long waits, rushed visits, and vague answers, chatbots feel more responsive and empathetic. Useful at times, but risky too. #AIinHealthcare https://t.co/hgV4DaaNcH via @NYTimes

Just finished Abundance by ⁦@ezraklein⁩ & ⁦@DKThomp⁩. A sharp look at why we struggle to build. From policy gridlock to cultural hesitation and what it would take to accelerate progress. Challenging, optimistic, and worth reading. #Abundance

Listening to the latest on brain-computer interfaces made clear how quickly this field is advancing. Implantable chips restoring function in conditions like vision loss or motor paralysis is no longer speculative, it’s becoming real. #BCI #FutureOfMedicine

Just listened to a piece on how our biological age may be rising faster than before. Obesity, stress, poor sleep, heat, and lifestyle all play a part, but research shows we can reverse some of it. Aging isn’t fixed; it’s negotiable. #Longevity #HealthAging

The FDA just tightened access to Elevidys, a gene therapy for Duchenne, after two teens died from liver failure. It’s a reminder that even exciting new treatments still need careful safety checks. #genetherapy https://t.co/tZfsGDa3oz via @NYTimes

We are proud of our latest CP recruit faculty member and the work she has started in @UofUPathology and @ARUPLabs.

Watching @SecKennedy back the White House deal on obesity drugs after years of blasting them is wild. GLP-1s are now “tools,” not villains. Big shift, but the politics around these meds might be even messier than the science. #healthpolicy https://t.co/HjcN3LgrcE via @NYTimes